Detalles de la búsqueda
1.
Benefit and toxicity of programmed death-1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study.
Br J Dermatol
; 187(3): 401-410, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35293617
2.
Seasonal patterns of toxicity in melanoma patients treated with combination anti-PD-1 and anti-CTLA-4 immunotherapy.
Eur J Cancer
; 198: 113506, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38184928
3.
Brief Report: Real-World Toxicity and Survival of Combination Immunotherapy in Pleural Mesothelioma-RIOMeso.
J Thorac Oncol
; 19(4): 636-642, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38036250
4.
Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case series.
J Immunother Cancer
; 12(1)2024 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38296594
5.
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study.
Eur J Cancer
; 175: 224-235, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36155116
6.
Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis.
Data Brief
; 45: 108649, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36426082
7.
Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti-PD-1 Monotherapy.
Clin Cancer Res
; 27(21): 5993-6000, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34376536
Resultados
1 -
7
de 7
1
Próxima >
>>